A comprehensive review on nutraceuticals: therapy support and formulation challenges
WATER, TRIETHYLHEXANOIN, HYDROGENATED POLY(C6-14 OLEFIN), BUTYLENE GLYCOL, 1,2-HEXANEDIOL, METHYLPROPANEDIOL, NIACINAMIDE, PHENYL TRIMETHICONE, DIETHOXYETHYL SUCCINATE, POLYGLYCERYL-10 MYRISTATE, FRAGRANCE, HIPPOPHAE RHAMNOIDES OIL, ETHYLHEXYLGLYCERIN, ALLANTOIN, HYDROGENATED LECITHIN, HIBISCUS ESCULENTUS FRUIT EXTRACT, CORCHORUS OLITORIUS LEAF EXTRACT, CARUM PETROSELINUM (PARSLEY) EXTRACT, GLUTATHIONE, SODIUM GLUCONATE, ADENOSINE, CELLULOSE GUM, HEXYL CINNAMAL, GLUCONOLACTONE, MELIA AZADIRACHTA LEAF EXTRACT, LINALOOL, MELIA AZADIRACHTA FLOWER EXTRACT, LAVANDULA ANGUSTIFOLIA (LAVENDER) FLOWER WATER, HYACINTHUS ORIENTALIS (HYACINTH) EXTRACT, CENTAUREA CYANUS FLOWER EXTRACT, CHAMOMILLA RECUTITA (MATRICARIA) FLOWER/LEAF EXTRACT, CURCUMA LONGA (TURMERIC) ROOT EXTRACT, BORAGO OFFICINALIS EXTRACT, SALVIA SCLAREA (CLARY) EXTRACT, LIMONENE, ALPHA-ARBUTIN, OCIMUM SANCTUM LEAF EXTRACT, CORALLINA OFFICINALIS EXTRACT, THIOCTIC ACID, BIOTIN, BIOTINOYL TRIPEPTIDE-1, ACETYL HEXAPEPTIDE-8, TRIPEPTIDE-1, TRIPEPTIDE-3, MYRISTOYL PENTAPEPTIDE-17, HEXAPEPTIDE-9
Herein, we tested a variety of Cox-1/Cox-2 non-selective NSAIDs, namely ibuprofen, tylenol, aspirin and naproxen and report that they blunt IgM and IgG synthesis in stimulated human peripheral blood mononuclear cells (PBMC)
Barale C, et al
Front Pharmacol 13:1036423
